Skip to main content
. 2022 Apr 25;11(2):863–880. doi: 10.1007/s40120-022-00350-y

Fig. 2.

Fig. 2

Calibration of treatment effect on amyloid level during and beyond trial time horizon. AD Alzheimer’s disease, CDRSB Clinical Dementia Rating Scale-Sum of Boxes, MCI mild cognitive impairment, PET positron emission tomography, SoC standard of care, SUVr standard uptake value ratio